"Carforson" involves a bone marrow section/tissue extraction needle
Taiwan·Risk Class 2·BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC.·Registered Dec 06, 2004 – Dec 06, 2024Expired- Analysis ID
- fb1f1b86ca51d14c52006548e26dcd09
- Customs Code
- DHA00601094501
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- For details, it is Chinese approved copy of the imitation order.
- Product Type (Level 1)
- H Gastroenterology and urology
- Import Information
- import
- Registration Date
- Dec 06, 2004
- Expiry Date
- Dec 06, 2024
Access comprehensive regulatory information for "Carforson" involves a bone marrow section/tissue extraction needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fb1f1b86ca51d14c52006548e26dcd09 and manufactured by BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.